Dyne Therapeutics (Part 2) – Meet the DM Drug Developers 2025

Dyne Therapeutics presents updates on their DM1 program and their ongoing ACHIEVE study on Zeleciment basivarsen («z-basivarsen», also known as DYNE-101).

Click here to learn more about Dyne Therapeutics.

Register once and you can join any of our 2025 Meet the DM Drug Developer webinars! Click here to find all our upcoming Meet the DM Drug Developer dates and previously recorded sessions. >>>

Questions or comments? Contact MDF at 415-800-7777 or at info@myotonic.org.

 

 

Thank you to our 2025 Community Education Webinar Series Sponsors, Avidity Biosciences and Dyne Therapeutics!

MDF Resources referenced in this video:

• Toolkits & Publications
• Support Groups
• Calendar of Events
• DM Drug Development Pipeline
• Myotonic Dystrophy Family Registry
• Ask the Expert series
• Study & Trial Resource Center
• Sign up for My Dispatch, our monthly e-newsletter!